Skip to main content

Articles

Leukemia, Oncology
Asciminib, First-in-Class STAMP Inhibitor, Superior to Bosutinib in Chronic-Phase CML
Phoebe Starr
Read More
Multiple Myeloma, Oncology, Bispecific Antibodies
Bispecific Antibodies in Phase 1 Studies Show Promising Efficacy in Heavily Pretreated Patients with Multiple Myeloma
Wayne Kuznar
Read More
Gastroenterology
Ruxolitinib in Graft-versus-Host Disease: Practice-Changing Results
Phoebe Starr
Read More
FDA Approvals
FDA Approves Tepmetko for Metastatic NSCLC and MET Exon 14 Skipping Alterations
Read More
FDA Approvals
FDA Approves Margenza for Treatment of Metastatic HER2-Positive Breast Cancer
Read More
FDA Approvals
Orgovyx First FDA-Approved Oral Hormone Therapy for Advanced Prostate Cancer
Read More
ESMO 2020 Highlights
Sotorasib, First-in-Class KRAS G12C Inhibitor, Hailed as “Triumph of Drug Discovery”
Phoebe Starr
Read More
FDA Approvals
Keytruda plus Chemotherapy Approved for Unresectable or Metastatic Triple‑Negative Breast Cancer
Read More
FDA Approvals
Opdivo plus Yervoy First Immunotherapy Approved for Unresectable Malignant Pleural Mesothelioma
Read More
FDA Approvals
FDA Approves First Prostate-Specific Membrane Antigen–Targeted PET Imaging Drug for Prostate Cancer
Read More
Page 27 of 244
Results 261 - 270 of 2434